Grifols, Talecris deal

Talecris said it and Grifols received a request for additional information from the U.S. Federal Trade Commission (FTC) regarding Grifols' plans to acquire Talecris. Grifols announced in June that it planned to acquire the fellow plasma protein company in a cash and stock deal valued at about $3.4 billion (see BioCentury, June 14). ...